The FDA and Corbus Pharmaceuticals Holdings, Inc., have agreed on second-line registrational study designs evaluating CRB-701 ...
Abstract: Drug recommendation systems in healthcare face the fundamental challenge of simultaneously optimizing multiple critical objectives including therapeutic efficacy, safety constraints, dosage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results